Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response-guided boceprevir + PEGIFN/RBV in HIV/HCV coinfected patients
2012-005591-33Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of boceprevir in chronic hepatitis C virus infection, human immunodeficiency virus infection (HIV), sponsored by Medical University of Vienna. Started Jun 2013; status: completed.
02
Drugs
boceprevir
03
Conditions
chronic hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-005591-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005591-33.